130 Characterizing ocular adverse events in clinical trials of GLP-1 drugs using weighted and unweighted participant counts results reported on ClinicalTrials.gov
Objectives/Goals: Ocular adverse events (OAEs) have been associated with GLP-1 use in clinical studies. This study aims to describe the proportion and distribution of ocular adverse events by treatment arm, including serious and non-serious events, in phase 2-4 clinical trials of GLP-1 drugs using p...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Cambridge University Press
2026-04-01
|
| Schriftenreihe: | Journal of Clinical and Translational Science |
| Online-Zugang: | https://www.cambridge.org/core/product/identifier/S2059866126103422/type/journal_article |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|